1.Associations between long working hours, leisure-time physical activity, and work-related musculoskeletal disorders among multi-industry workers in Nanchong
Jing QIU ; Hairong WANG ; Wei ZHOU
Journal of Environmental and Occupational Medicine 2025;42(5):602-607
Background Work-related musculoskeletal disorders (WMSDs) are considered to be one of the biggest health problems in the workplace, seriously affecting the productivity and quality of life of the working population. Long working hours may associate with WMSDs, and leisure-time physical activity (LTPA) is beneficial for WMSDs. However, the independent and combined effects of these two factors on WMSDs remain poorly understood. Objective To explore the independent and joint relationships between long working hours, leisure time physical activity (LTPA), and WMSDs, and to provide a basis for prevention and intervention of WMSDs. Methods A cross-sectional survey was conducted among
2.Analyzing the reasons for and prevention of serious complications after general anesthesia in children with obstructive sleep apnea.
Lan CHEN ; Dabo LIU ; Jianwen ZHONG ; Shuyao QIU ; Yilong ZHOU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(2):168-172
Objective:To explore the causes and preventive measures of respiratory arrest following general anesthesia in children with obstructive sleep apnea (OSA), in order to enhance the safety of OSA surgeries under general anesthesia. Methods:A retrospective analysis was conducted on the clinical and follow-up data of four pediatric cases that experienced respiratory arrest after general anesthesia for OSA at Shenzhen Hospital of Southern Medical University from March 2020 to March 2022. Results:All four children exhibited varying degrees of decreased blood oxygen saturation, cyanosis, and loss of consciousness after OSA surgery under general anesthesia, with one case experiencing respiratory and cardiac arrest. Through emergency rescue measures such as oxygen supplementation, suctioning, positive pressure ventilation, awakening, and cardiopulmonary resuscitation, all four children were stabilized. Follow-up after 2 to 6 months showed no complications. The main reasons for the occurrence are analyzed as: residual anesthetic drugs, characteristics of the OSA disease, and the unique aspects of the pediatric population. Conclusion:Children undergoing general anesthesia for OSA should be closely monitored for vital signs after surgery. If respiratory suppression occurs, active rescue measures should be taken to avoid serious consequences.
Humans
;
Sleep Apnea, Obstructive/surgery*
;
Anesthesia, General/adverse effects*
;
Retrospective Studies
;
Child
;
Postoperative Complications/prevention & control*
;
Male
;
Female
;
Child, Preschool
3.Laser surgery for bilateral vocal cord paralysis in children: 2 cases report and literature review.
Chao CHEN ; Yilong ZHOU ; Dabo LIU ; Peiyun ZHUANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(2):173-176
Vocal cord paralysis ( VCP ) refers to the movement disorder of the vocal cord caused by the damage of the motor nerve conduction pathway that dominates the laryngeal muscles, which can be accompanied by sensory nerve disorder of the larynx. Symptoms of bilateral vocal cord paralysis include crying hoarseness, sucking cough, and laryngeal stridor, which can lead to asphyxia in severe cases. Our team recently used CO2 laser to treat such children, but the prognosis varies significantly. Case 1: A 2-year-old male, who had undergone tracheotomy 2 years prior, was diagnosed with "bilateral vocal cord paralysis with grade Ⅱ laryngeal obstruction" after birth. He maintained a tracheostomy until recently. Electronic laryngoscopy showed that the bilateral vocal cords were fixed in the midline, with a glottic fissure of about 1 mm. After surgical treatment, the outcome was good, and there was no recurrence during follow-up. A 1-year-old female, who had undergone tracheotomy over a year ago, was diagnosed with ' ①bilateral vocal cord paralysis; ②laryngomalacia; ③neonatal pneumonia.' She maintained a tracheostomy since then. Electronic laryngoscopy revealed that the bilateral vocal cords were retracted and fixed, with a glottic fissure of about 0.5 mm and limited vocal cord abduction. The postoperative outcome for this child was not good, and the tracheostomy tube was not removed.
Humans
;
Vocal Cord Paralysis/surgery*
;
Male
;
Child, Preschool
;
Female
;
Laser Therapy
;
Infant
4.Non-invasive positive pressure ventilation for residual OSAHS with hypercapnia: a case report.
Liqiang YANG ; Shuyao QIU ; Jianwen ZHONG ; Xiangqian LUO ; Yilong ZHOU ; Jinhong ZENG ; Dabo LIU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(2):177-180
This case report outlines the treatment of an 11-year-old female who underwent adenotonsillectomy six years ago for snoring but experienced postoperative inefficacy. Her symptoms worsened two weeks before readmission, with increased snoring and sleep apnea, disabling her from lying down to sleep. She was readmitted on December 1, 2023, and diagnosed with severe obstructive sleep apnea hypopnea syndrome and hypercapnia. Automatic BiPAP alleviated her symptoms, with sleep breathing parameters normalizing during treatment. Follow-up at one month showed significant acceleration in her growth and resolution of her hypersomnolence issue.
Humans
;
Female
;
Child
;
Hypercapnia/complications*
;
Sleep Apnea, Obstructive/complications*
;
Positive-Pressure Respiration
;
Noninvasive Ventilation
5.Magnolol inhibits appetite and causes visceral fat loss through Growth/differentiation factor-15 (GDF-15) by activating transcription factor 4-CCAAT enhancer binding protein γ-mediated endoplasmic reticulum stress responses.
Keru CHENG ; Yanyun ZHOU ; Yilong HAO ; Shengyun WU ; Nanping WANG ; Peng ZHANG ; Yinfang WANG
Chinese Journal of Natural Medicines (English Ed.) 2025;23(3):334-345
Magnolol, a compound extracted from Magnolia officinalis, demonstrates potential efficacy in addressing metabolic dysfunction and cardiovascular diseases. Its biological activities encompass anti-inflammatory, antioxidant, anticoagulant, and anti-diabetic effects. Growth/differentiation factor-15 (GDF-15), a member of the transforming growth factor β superfamily, is considered a potential therapeutic target for metabolic disorders. This study investigated the impact of magnolol on GDF-15 production and its underlying mechanism. The research examined the pharmacological effect of magnolol on GDF-15 expression in vitro and in vivo, and determined the involvement of endoplasmic reticulum (ER) stress signaling in this process. Luciferase reporter assays, chromatin immunoprecipitation, and in vitro DNA binding assays were employed to examine the regulation of GDF-15 by activating transcription factor 4 (ATF4), CCAAT enhancer binding protein γ (CEBPG), and CCCTC-binding factor (CTCF). The study also investigated the effect of magnolol and ATF4 on the activity of a putative enhancer located in the intron of the GDF-15 gene, as well as the influence of single nucleotide polymorphisms (SNPs) on magnolol and ATF4-induced transcription activity. Results demonstrated that magnolol triggers GDF-15 production in endothelial cells (ECs), hepatoma cell line G2 (HepG2) and hepatoma cell line 3B (Hep3B) cell lines, and primary mouse hepatocytes. The cooperative binding of ATF4 and CEBPG upstream of the GDF-15 gene or the E1944285 enhancer located in the intron led to full-power transcription of the GDF-15 gene. SNP alleles were found to impact the magnolol and ATF4-induced transcription activity of GDF-15. In high-fat diet ApoE-/- mice, administration of magnolol induced GDF-15 production and partially suppressed appetite through GDF-15. These findings suggest that magnolol regulates GDF-15 expression through priming of promoter and enhancer activity, indicating its potential as a drug for the treatment of metabolic disorders.
Lignans/pharmacology*
;
Growth Differentiation Factor 15/metabolism*
;
Animals
;
Biphenyl Compounds/pharmacology*
;
Endoplasmic Reticulum Stress/drug effects*
;
Activating Transcription Factor 4/genetics*
;
Mice
;
Humans
;
Male
;
Magnolia/chemistry*
;
CCAAT-Enhancer-Binding Proteins/genetics*
;
Mice, Inbred C57BL
6.Investigation and analysis of the current status of transjugular intrahepatic portosystemic shunt treatment for portal hypertension in China
Haozhuo GUO ; Meng NIU ; Haibo SHAO ; Xinwei HAN ; Jianbo ZHAO ; Junhui SUN ; Zhuting FANG ; Bin XIONG ; Xiaoli ZHU ; Weixin REN ; Min YUAN ; Shiping YU ; Weifu LYU ; Xueqiang ZHANG ; Chunqing ZHANG ; Lei LI ; Xuefeng LUO ; Yusheng SONG ; Yilong MA ; Tong DANG ; Hua XIANG ; Yun JIN ; Hui XUE ; Guiyun JIN ; Xiao LI ; Jiarui LI ; Shi ZHOU ; Changlu YU ; Song HE ; Lei YU ; Hongmei ZU ; Jun MA ; Yanming LEI ; Ke XU ; Xiaolong QI
Chinese Journal of Radiology 2024;58(4):437-443
Objective:To investigate the current situation of the use of transjugular intrahepatic portosystemic shunt (TIPS) for portal hypertension, which should aid the development of TIPS in China.Methods:The China Portal Hypertension Alliance (CHESS) initiated this study that comprehensively investigated the basic situation of TIPS for portal hypertension in China through network research. The survey included the following: the number of surgical cases, main indications, the development of Early-TIPS, TIPS for portal vein cavernous transformation, collateral circulation embolization, intraoperative portal pressure gradient measurement, commonly used stent types, conventional anticoagulation and time, postoperative follow-up, obstacles, and the application of domestic instruments.Results:According to the survey, a total of 13 527 TIPS operations were carried out in 545 hospitals participating in the survey in 2021, and 94.1% of the hospital had the habit of routine follow-up after TIPS. Most hospitals believed that the main indications of TIPS were the control of acute bleeding (42.6%) and the prevention of rebleeding (40.7%). 48.1% of the teams carried out early or priority TIPS, 53.0% of the teams carried out TIPS for the cavernous transformation of the portal vein, and 81.0% chose routine embolization of collateral circulation during operation. Most of them used coils and biological glue as embolic materials, and 78.5% of the team routinely performed intraoperative portal pressure gradient measurements. In selecting TIPS stents, 57.1% of the hospitals woulel choose Viator-specific stents, 57.2% woulel choose conventional anticoagulation after TIPS, and the duration of anticoagulation was between 3-6 months (55.4%). The limitation of TIPS surgery was mainly due to cost (72.3%) and insufficient understanding of doctors in related departments (77.4%). Most teams accepted the domestic instruments used in TIPS (92.7%).Conclusions:This survey shows that TIPS treatment is an essential part of treating portal hypertension in China. The total number of TIPS cases is far from that of patients with portal hypertension. In the future, it is still necessary to popularize TIPS technology and further standardize surgical indications, routine operations, and instrument application.
7.Latest advances in the development of tuberculosis vaccines in global clinical trials: a review
Fangbin ZHOU ; Yilong ZHANG ; Dongmei ZHANG
Chinese Journal of Schistosomiasis Control 2024;36(2):201-206
Tuberculosis (TB) remains one of the biggest infectious killers worldwide. Vaccine is the most satisfactory tool for prevention of TB; however, Bacillus Calmette-Guérin (BCG), the widely used vaccine in clinical for the prevention of TB, has limitations in protective effects. Development of novel TB vaccines is therefore of urgent need. Currently, there are 15 novel TB vaccine candidates in clinical trials, including live-attenuated vaccines, inactivated vaccines, subunit vaccines and viral-vectored vaccines, which open the door for the ultimate target of the End TB Strategy. This review summarizes the latest advances in the development of TB vaccines in global clinical trials, so as to provide insights into TB control.
8.Clinical pathway in Chinese county for lung cancer diagnosis and treatment (2023 edition)
Chinese Journal of Oncology 2024;46(1):19-39
Lung cancer (LC) is the leading cause of death among patients with cancer both in worldwide and China. China accounts for 11.4% of the total number of cancer cases and 18.0% of the total number of cancer deaths in the world. Standardizing the diagnosis and treatment of LC is a key measure to improve the survival rate of LC patients and reduce the mortality rate. However, county hospitals generally face the problem of inaccessibility to advanced diagnostic and treatment technologies. Therefore, when developing quality control standards and clinical diagnosis and treatment specifications, it is necessary to combine the actual situation of county hospitals and formulate specific recommendations. The recommendations of treatment measures also need to consider the approval status of indications and whether it is included in the National Reimbursement Drug List (NRDL), to ensure the access to medicines. In order to solve the above problems, based on existing guidelines at home and abroad and the clinical work characteristics of county hospitals, the first clinical pathway in Chinese county for LC diagnosis and treatment (2023 edition) was compiled. This pathway elaborated on the imaging diagnosis, pathological diagnosis, molecular testing, and precision medicine based on histological-pathological types, tumor-node-metastasis (TNM) classification, and molecular classification, developed different diagnosis and treatment processes for different types of LC patients. Simultaneously, according to the actual work situation of county hospitals, the diagnosis and treatment recommendations in clinical scenarios are divided into basic strategies and optional strategies for elaboration. The basic strategies are the standards that county hospitals must meet, while the optional strategies provide more choices for hospitals, which are convenient for county doctors to put into clinical practice. All the recommended diagnostic and treatment plans strictly refer to existing guidelines and consensus, ensuring the scientificity.
9.Research on the Path Selection of Attracting Overseas Medical Consumption Backflow under the New Development Pattern of"Dual Circulation"
Chinese Health Economics 2024;43(5):28-33
Attracting the return of overseas medical consumption is not only a driving force for promoting supply side structural reform and improving industrial development quality and efficiency under the current"dual circulation"new development pattern,but also a powerful lever and new engine for promoting high-quality economic development.The main reasons for attracting the outflow of domestic medical consumption include the pursuit of advanced medical technology from abroad,the attraction of high-quality medical services from overseas,the huge price difference between domestic and foreign medical consumption,and domestic policies,laws,and institutional restrictions.Measures need to be taken to improve the level of medical technology,increase the supply of medical consumption,improve the quality of medical services,optimize the medical consumption environment,and reduce medical service costs to attract the return of overseas medical consumption.
10.The Driving Factors and Implementation Path of Attracting Overseas Medical Consumption
Chinese Health Economics 2024;43(11):15-20,26
Attracting overseas medical consumption is the driving force behind the development of the medical industry in China's current"dual circulation"new development pattern.The progress of domestic medical technology and the improvement of service quality,the development of the economy and society,the enhancement of residents'health awareness,the increase of government investment in the health field,the advantages of the medical market and price competition,the guidance and support of government policies,international medical exchanges and cooperation,and the improvement of the medical insurance system are the main driving factors for attracting overseas medical consumption.Improving the level of medical technology,stimulating the vitality of attracting medical consumption,increasing the supply of medical consumption,unleashing the potential of attracting medical consumption,improving the quality of medical services,building support for attracting medical consumption to return,optimizing the medical consumption environment,creating an atmosphere for attracting medical consumption,and regulating overseas medical consumption,injecting the momentum of attracting medical consumption to return are the main implementation ways to attract overseas medical consumption to return.

Result Analysis
Print
Save
E-mail